Cohort Study in Uganda Comparing Artesunate + Amiodaquine (Coarsucam) Versus Artemether + Lumenfantrine (Coartem) in the Treatment of Repeated Uncomplicated Plasmodium Falciparum Malaria Attacks

PHASE4CompletedINTERVENTIONAL

Enrollment

413

Participants

Timeline

Start Date

June 30, 2008

Primary Completion Date

June 30, 2010

Study Completion Date

June 30, 2010

Conditions

Malaria

Interventions

DRUG

Coarsucam

Oral route, once daily, dose according to bodyweight range Duration of treatment: 3 days

DRUG

Coartem

Oral route, twice daily, dose according to bodyweight range Duration of treatment: 3 days

Trial Locations (1)

Sanofi-aventis administrative office, Kampala